The field of organ perfusion is emerging as one of the most dynamic and strategic areas in transplantation medicine. Aferetica has identified the European market as a key environment to advance the international expansion of its innovative PerLife®ᵖʳᵒ system — a patented technology designed to recover “marginal” organs and offer new therapeutic opportunities to patients.
This strategy will be pursued through a combined approach:
- Online, by implementing a digital promotion plan and leveraging dedicated services for internationalization;
- Offline, by participating in selected international scientific congresses aligned with leading European transplant societies.
Through this pathway, Aferetica aims to strengthen competitiveness, expand scientific collaborations, and promote PerLife®ᵖʳᵒ innovation across Europe, addressing the growing demand for advanced solutions in transplantation.
